the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Facebook, Instagram-owner Meta has new AI-based political ad rules

WASHINGTON: Facebook and Instagram-owner Meta Platforms Inc has introduced new rules regarding the use of artificial intelligence (AI) for political advertising.

Meta has decided to bar political campaigns and advertisers in regulated industries from using its new generative AI or AI-based advertising products. With this move, Meta aims to prevent the possible misuse of AI-based tools and the spread of election misinformation, reported German news agency (dpa).

In updates posted to its help centre, Meta said, “As we continue to test new Generative AI ads creation tools in Ads Manager, advertisers running campaigns that qualify as ads for housing, employment or credit or social issues, elections, or politics, or related to health, pharmaceuticals or financial services aren’t currently permitted to use these Generative AI features.”

According to the company, this approach will allow it to better understand potential risks and build the right safeguards for the use of Generative AI in ads that relate to potentially sensitive topics in regulated industries.

Meta reportedly announced recently that it was starting to expand advertisers’ access to AI-powered advertising tools.

Such tools can instantly create backgrounds, image adjustments, and variations of ad copy in response to simple text prompts.

Among other tech majors, Alphabet’s Google, which recently announced the launch of generative AI ads tools, is said to block a list of political keywords from being used as prompts.

TikTok and Snapchat owner Snap also have banned political ads.–Bernama-dpa

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings